Mendus AB (OSTO:IMMU) Common Stock: kr62.59 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSTO:IMMU Mendus AB OSTO:IMMU
28 GF Score
Price kr6.36
! 2 Warning Signs
View Full Analysis

What is Mendus AB Common Stock?

Mendus AB OSTO:IMMU -6.74% 28 Common Stock is kr62.59 Mil as of Mar. 2026. GuruFocus rates OSTO:IMMU with a GF Score™ of 28/100. The stock has 2 warning signs investors should review.

Mendus AB's quarterly common stock increased from Sep. 2025 (kr52.09 Mil) to Dec. 2025 (kr62.59 Mil) but then stayed the same from Dec. 2025 (kr62.59 Mil) to Mar. 2026 (kr62.59 Mil).

Mendus AB's annual common stock increased from Dec. 2023 (kr43.16 Mil) to Dec. 2024 (kr50.36 Mil) and increased from Dec. 2024 (kr50.36 Mil) to Dec. 2025 (kr62.59 Mil).

Mendus AB Common Stock Historical Data

* Premium members only.

The historical data trend for Mendus AB's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Mendus AB Common Stock Chart

Mendus AB Annual Data
Trend Jun16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9.97 9.97 43.16 50.36 62.59

Mendus AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 50.36 52.09 52.09 62.59 62.59
OSTO:IMMU
28GF Score
Mendus AB OSTO:IMMU
Common Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Mendus AB Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of kr62.59 Mil mean?
Mendus AB (OSTO:IMMU) has a Common Stock of kr62.59 Mil as of Mar. 2026. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Mendus AB and its competitors.
Is Mendus AB's Common Stock too high?
Mendus AB's current Common Stock is kr62.59 Mil. Overall, Mendus AB has a GF Score™ of 28/100, reflecting its overall financial health beyond just this single metric.
How does Mendus AB's Common Stock compare to VRTX and REGN?
Mendus AB's Common Stock of kr62.59 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Biotechnology company?
A good Common Stock depends on the Biotechnology industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Mendus AB and its competitors. Mendus AB's current Common Stock is kr62.59 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mendus AB stock overvalued right now?
Mendus AB (OSTO:IMMU) has a current Common Stock of kr62.59 Mil. The current Common Stock is kr62.59 Mil. Mendus AB's overall GF Score™ is 28/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Mendus AB (OSTO:IMMU), the current Common Stock is kr62.59 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Mendus AB Business Description

Other Exchanges 1YG0:Germany
Address Vastra Tradgardsgatan 15, Stockholm, SWE, 11153
Mendus AB is a clinical-level biopharmaceutical company based on the company's allogeneic dendritic cell biology focused on the development of immunotherapies that address tumor recurrence and hard-to-treat established tumors. Its operations consist of research and development for pharmaceuticals. The company's Pipeline includes: Vididencel, and Ilixadencel.
28GF Score

Get the complete analysis for OSTO:IMMU

Common Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr6.36
Price